Prognostic analysis suggested that elevated FAM111B expression may function as an adverse prognostic biomarker in 10 cancer types, ACC, KICH, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PCPG, and UVM (Figure 1B). This evidence concerns the gene FAM111B and cancer.